Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from GNI Group ( (JP:2160) ) is now available.
GNI Group Ltd. announced that all agenda items related to the reverse merger between its subsidiary Cullgen Inc. and Pulmatrix, Inc. have been approved by Pulmatrix’s shareholders. This approval fulfills a key condition for Cullgen’s listing on the Nasdaq market, with only the China Securities Regulatory Commission’s approval pending. If the listing is delayed, the deconsolidation and recognition of a one-time gain will shift to the third quarter of 2025 or later, but the impact on GNI Group’s earnings forecast is expected to be limited.
The most recent analyst rating on (JP:2160) stock is a Buy with a Yen3700.00 price target. To see the full list of analyst forecasts on GNI Group stock, see the JP:2160 Stock Forecast page.
More about GNI Group
Average Trading Volume: 2,582,016
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen193B
Learn more about 2160 stock on TipRanks’ Stock Analysis page.